Telitacicept for refractory cystitis associated with severe systemic lupus erythematosus: A case report
This case highlights the therapeutic potential of telitacicept for SLE patients who are unresponsive to conventional therapies, particularly those with severe manifestations such as lupus cystitis.
Authors
- Shuo Yang (ORCID: https://orcid.org/0000-0003-4145-7173)
- Gui-Chen Ling
- Shan Zhang (ORCID: https://orcid.org/0009-0005-2501-6038)
- Jianyong Zhang (ORCID: https://orcid.org/0000-0002-1877-2776)
- Zhiling Li (ORCID: https://orcid.org/0000-0002-1467-0641)
- Yongjie Guo
- Jing-Jing Xie
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Nanjing University of Chinese Medicine (CN)
- Shenzhen Pingle Orthopedic Hospital (CN)
Publication Details
- Journal
- Lupus
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1177/09612033241309838
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanming Project of Medicine in Shenzhen